6640--SARS-CoV-2 Antigen test kits and COVID Antigen Digital Immunoassay readers (automated)
Closed Pre-Solicitation Posted
- Solicitation number
- 36C24626Q0060
- Agency
-
Veterans Integrated Service Network 6
Veterans Health Administration, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Place of performance
- Fayetteville Vamc 2300 Ramsey Street Fayetteville NC 28301
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6, specifically the Fayetteville VA Medical Center in North Carolina, is conducting market research for COVID-19 rapid detection SARS-CoV-2 antigen test kits and COVID antigen digital immunoassay readers (automated). The procurement falls under NAICS code 325413 (In-Vitro Diagnostic Substance Manufacturing) and PSC code 6640 (Laboratory Equipment and Supplies). The test kits must be FDA Emergency Use Authorization (EUA) approved and restricted to high complexity and moderate complexity testing for use in point-of-care settings including inpatient, outpatient, and employee occupational health environments, as well as for serial testing of asymptomatic individuals. Interested vendors must submit responses by 8:00 AM EST on September 30, 2025, including company information, business size classification, socioeconomic category status (8(a), HUBZone, Service-Disabled Veteran-Owned/Veteran-Owned Small Business), qualifications, capabilities statements, and authorized distributor documentation. The evaluation will focus on demonstrating the ability to meet the specified FDA approval requirements and testing complexity standards.
This sources sought notice does not include any set-aside designation, operating under a "No Set-Aside Used" classification that makes it available to all qualified contractors regardless of size or socioeconomic status. No incumbent contractors or current service providers are identified in the documentation, and no specific award values, budget ranges, or quantity requirements are disclosed at this preliminary market research stage. The notice emphasizes this is strictly an information-gathering exercise with no guarantee of future solicitation or contract award. The government has made clear it will not reimburse any costs associated with responding to this sources sought request and reserves the right to pursue any acquisition approach without being bound by the information collected. The tight six-day response window from posting on September 24, 2025, to the September 30, 2025, deadline indicates the agency's urgency in conducting this market assessment for COVID-19 testing capabilities.
Notice text
Sources Sought Notice Only. This is not a request for bids, quotes, or proposals. The purpose of this notice is to conduct market research and obtain information from qualified potential offerors. No formal solicitation document exists at this time. The Government is not obligated to, nor will it pay for or reimburse any costs associated with responding to these sources sought synopsis request. This notice shall not be construed as a commitment by the Government to issue a solicitation or ultimately award a contract, nor does it restrict the Government to a particular acquisition approach. The Government will in no way be bound to this information if any solicitation is issued.
The Fayetteville VAMC located at 2300 Ramsey Street, Fayetteville, NC, 28301 is seeking potential sources capable of providing point of care COVID-19 Rapid Detection of SARS-CoV-2 Antigen test kits and Covid Antigen Digital Immunoassay readers (automated). COVID-19 Rapid Detection of SARS-CoV-2 Antigen test kits must be FDA EUA approved for and restricted to high complexity and moderate complexity. The kits and readers are required for the rapid detection of the presence or absence of SARS-CoV-2 antigens. Respiratory specimens are taken at the point of care at inpatient, outpatient, and employee occupational health settings. Specimens are also collected for serially testing from asymptomatic individuals at the Fayetteville VA Medical Center and associated clinics.
Responses to this source sought notice should include the following: name and address of company, business size (large or small): identify whether or not firm falls into any of the following socioeconomic categories-8(a), HUBZone, Services Disabled Veteran-Owned/Veteran-Owned Small Business; provide a brief description of qualifications, capabilities statement, authorized distributor documentation, and any other pertinent information which demonstrates the ability to meet the above requirement.
Â
Subject line: COVID 19 kits and reader. All responses shall be submitted in the form of email to Cherisse Hall Cherisse.Hall@va.gov. Telephone responses will not be accepted. Responses must be received in writing no later than 08:00am EST on September 30, 2025.
NAICS 325413 In-Vitro Diagnostic Substance Manufacturing
PSC 6640 Laboratory Equipment and Supplies
Files
| File | Type | Posted |
|---|---|---|
| 36C24626Q0060.docx | DOCX document |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity